Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
µ-opioid receptor–mediated dopamine release in alcohol dependence
2005-001017-17Phase 4Active
- Sponsor
- RWTH Aachen University
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil in alcohol dependence (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Dopamine release after opioid agonist. Started Apr 2006; status: active.
02
Drugs
remifentanil
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2005-001017-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001017-17.